Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Total flavonoids of Rhizoma drynariae influence ferroptosis in osteoblasts via miR-205-5p/GPX4 axis

Enjun Kong¹, Yan Xu², Haichen Yang³

¹Department of Emergency, The Peopleâ€™s Hospital of Danyang and Affiliated Danyang Hospital of Nantong University, Danyang 212300, China; ²Department of Rheumatic Hematology, The Peopleâ€™s Hospital of Danyang and Affiliated Danyang Hospital of Nantong University, Danyang 212300, China; ³Department of Emergency, Huai'an Hospital Affiliated of Xuzhou Medical University and Huai'an Second People's Hospital, Huai'an 223002, China.

For correspondence:- Haichen Yang Email: yhc7873890462021@163.com

Accepted: 22 June 2023 Published: 31 July 2023

Citation: Kong E, Xu Y, Yang H. Total flavonoids of Rhizoma drynariae influence ferroptosis in osteoblasts via miR-205-5p/GPX4 axis. Trop J Pharm Res 2023; 22(7):1379-1386 doi: 10.4314/tjpr.v22i7.4

© 2023 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: This research investigated the biological effects of total flavonoids of Rhizoma Drynariae (TFRD) on osteoporosis in mice.

Methods: Mice were subjected to bilateral ovariectomy (OVX) to generate the osteoporosis model used, which was then intragastrically administered TFRD daily at a dose of 75 mg/kg. Bone loss was examined histologically using H&E staining. Moreover, erastin-treated primary osteoblasts were used to further analyze the effect of TFRD on ferroptosis. Reactive oxygen species (ROS), ferrous iron level, and CCK-8 method were employed to determine the protective influence of TFRD against ferroptosis in erastin-treated osteoblasts. The relationship between microRNA-205-5p (miR-205-5p) and glutathione peroxidase 4 (GPX4) was determined using luciferase assay.

Results: TFRD treatment inhibited OVX-induced bone mass loss, downregulated ferrous ion content, and increased the level of GPX4 in vivo (p < 0.01). Besides, TFRD treatment inhibited erastin-induced increases in ROS level and ferrous iron level, and promoted cell viability in vitro (p < 0.01). Moreover, TFRD increased GPX4 protein expression level (p < 0.01). Results from gain and loss experiments showed that GPX4 increased cell viability, and reduced ferrous ion and ROS levels in erastin-induced osteoblasts (p < 0.01, p < 0.001, respectively). Furthermore, miR-205-5p directly targeted GPX4 and negatively regulated GPX4 expression (p < 0.01, p < 0.001, respectively). Upregulation of GPX4 reversed the effect of miR-205-5p overexpression on cell viability, and reduced ferrous iron level and ROS levels in osteoblasts significantly.

Conclusion: TFRD may serve as an inhibitor of osteoblast ferroptosis during osteoporosis formation by down-regulating the expression of miR-205-5p which directly targets GPX4 in mouse osteoblasts. These findings indicate the therapeutic potential and underlying mechanism of action of TFRD.

Keywords: Flavonoids, Rhizoma drynariae, MiR-205-5p GPX4, Ferroptosis, Osteoblasts